Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
MARA: From Energy-to-Value — A High-Risk, High-Reward Infrastructure Trade
Long MARA on the transformation narrative; entry on weakness, stop tight, targets at prior structural highs
MARA positions itself as an energy-to-value infrastructure company — converting stranded or underutilized energy into digital-asset value while buil...
Scotiabank (BNS) - Buy on Durable Fundamentals and Cash Return; Trade Plan for a Clear Risk-Reward
Recent beats, steady quarterly CAD dividend lift, and healthier top-line mix make the bank a buy for income-focused investors with a medium-term horizon.
Bank of Nova Scotia remains structurally sound: over CAD 1.4 trillion of assets, a steady quarterly CAD 1.10 dividend most recently declared 12/02/202...
Nutrien: A Bottom-Fishing Turnaround — Income, Industry Tailwinds, and Cheap Optionality
Quarterly yield, retail moat and industry growth make NTR a tactical long for the patient contrarian
Nutrien (NTR) is the world’s largest fertilizer producer by capacity and the largest ag retailer in North America and Australia. At roughly $62.93 p...
Palantir's 114% Rule — Bootcamp Flywheel Is Lining Up for a Parabolic Breakout (Trade Plan)
Explosive top-line acceleration, improving margins and a bootcamp-driven commercial flywheel — tactical long with defined entry, stops and stretch targets.
Palantir just posted another quarter of accelerating revenue, margin expansion and cash generation. Q3 2025 revenue of $1.181B and operating income of...
Buy AMD for 2026: Position for AI GPU Share Gains and Margin Re-rating
Actionable long idea — entry, stops, and targets for a 2026 play on data-center GPUs and steady cash generation
AMD reported a strong Q3 FY2025 (quarter ended 09/27/2025) with revenue of $9.25B and net income of $1.24B. The company is executing on AI GPU strateg...
Applied Digital + EKSO: Buy the Spinout That Reframes the AI-Compute Story
ChronoScale transaction gives a clean go-to-market for GPU compute — buy on the setup with defined risk controls
Applied Digital's proposed spinout of its cloud arm and business combination with EKSO to form ChronoScale (announced 12/29/2025) is a clear corporate...
BP: Castrol Sale Could Unlock Value — Tactical Long with Dividend Support
Use the sale to get paid while you wait — entry around current levels, tight stop, two-tier targets over 6-12 months
BP's reported move to sell Castrol (details still emerging) is a near-term catalyst that could accelerate asset reallocation, shore up free cash flow ...
Cronos: Balance-Sheet Bulwark — Long Against Policy and M&A Upside
Strong cash, light liabilities and a cheap operating business create an asymmetric risk-reward for patient longs.
Cronos (CRON) is one of the rare cannabis names trading with a balance sheet that materially de-risks the equity. With roughly $824M cash and only ~$4...
Coupang (CPNG) After the Slide: Upgrade to Buy — Tactical Entry on Improving Cash Flow, But Litigation Cloud Remains
Stock is trading ~25% below recent highs; fundamentals improving, short-term trade plan favors a staged long with tight risk controls.
Coupang has quietly been converting revenue growth into positive operating income and rising operating cash flow across 2025, but a wave of December 2...
Cameco: From Uranium Miner to Energy-Scale Infrastructure Play
A position trade on CCJ that leans long the company’s Westinghouse-led infrastructure pivot — entry 90-95, stop 80, targets 120/150
Cameco is trading near $92.84 as of 12/30/2025 after a material rerating over the past year. The company still sources uranium but now derives the lar...
Biogen Relative Safety Profile, Leqembi Momentum — A Tactical Long with Defined Stops
Leqembi's uptake and safety edge vs. competing Alzheimer’s entrants make BIIB a tactical buy on dips; trade plan, catalysts, and guardrails below.
Biogen is positioned to defend and grow its Alzheimer’s franchise through Leqembi (lecanemab) adoption and an improving safety/regulatory narrative....
Adding to Celestica After a 3x Rally - My Trade Plan, Why I Still Believe, and What Could Break It
Strong quarterly cash conversion and hyperscaler-driven revenue mix justify adding here; tactical entry, stop and targets included.
Celestica (CLS) has more than tripled from winter lows on accelerating Connectivity & Cloud demand and improving margins. The company is converting st...